Form 4: IN8BIO Director Luba Greenwood Granted Stock Options

Director Luba Greenwood of IN8BIO, INC. was granted stock options to purchase 39,449 shares of common stock at an exercise price of $0.24 on December 19, 2024.

Summary

• On December 19, 2024, Luba Greenwood, a director of IN8BIO, INC., was granted stock options.
• These options allow Greenwood to purchase 39,449 shares of IN8BIO's common stock at an exercise price of $0.24 per share.
• The options vest on December 19, 2025, contingent upon Greenwood's continued service to the company.
• The options expire on December 19, 2034.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive as it reflects a standard practice of incentivizing a director with stock options, aligning their interests with shareholders.

Positives

• The granting of stock options to a director aligns their interests with those of the shareholders, incentivizing them to work towards the company's success.
• The vesting schedule encourages continued service and commitment from the director.

Future Outlook

There is no future outlook provided in this document.

Industry Context

This is a standard practice for incentivizing board members in publicly traded companies, particularly in the biotech industry where long-term growth is crucial.

Stakeholder Impact

• Shareholders may view this positively as it aligns the director's interests with the company's long-term success.
• Employees may see this as a sign of confidence in the company's future.

Key Dates